DarioHealth Corp (DRIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DarioHealth Corp (DRIO) has a cash flow conversion efficiency ratio of -0.097x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.03 Million) by net assets ($62.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DRIO days of operational coverage to measure how many days the company can operate on defensive assets alone.
DarioHealth Corp - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how DarioHealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
DarioHealth Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DarioHealth Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lunnon Metals Ltd
AU:LM8
|
-0.119x |
|
HRS Co. Ltd
KQ:036640
|
-0.004x |
|
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret
IS:ANGEN
|
-0.002x |
|
Sigong Tech Co. Ltd
KQ:020710
|
-0.056x |
|
Ultimovacs ASA
OL:ULTI
|
-0.299x |
|
Alset Ehome International Inc
NASDAQ:AEI
|
-0.012x |
|
2S Metal Public Company Limited
BK:2S
|
0.007x |
|
Dongwon Metal
KO:018500
|
0.257x |
Annual Cash Flow Conversion Efficiency for DarioHealth Corp (2012–2025)
The table below shows the annual cash flow conversion efficiency of DarioHealth Corp from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see DarioHealth Corp (DRIO) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $67.92 Million | $-25.94 Million | -0.382x | +28.67% |
| 2024-12-31 | $72.02 Million | $-38.56 Million | -0.535x | -2.48% |
| 2023-12-31 | $58.14 Million | $-30.38 Million | -0.522x | +12.64% |
| 2022-12-31 | $80.00 Million | $-47.84 Million | -0.598x | -1.50% |
| 2021-12-31 | $85.55 Million | $-50.41 Million | -0.589x | +6.47% |
| 2020-12-31 | $28.15 Million | $-17.74 Million | -0.630x | +24.30% |
| 2019-12-31 | $18.89 Million | $-15.72 Million | -0.832x | +35.24% |
| 2018-12-31 | $8.93 Million | $-11.47 Million | -1.285x | +52.30% |
| 2017-12-31 | $3.94 Million | $-10.62 Million | -2.694x | -310.34% |
| 2016-12-31 | $-6.54 Million | $-8.38 Million | 1.281x | +115.86% |
| 2015-12-31 | $777.00K | $-6.28 Million | -8.079x | -338.94% |
| 2014-12-31 | $-2.54 Million | $-8.58 Million | 3.381x | -96.16% |
| 2013-12-31 | $-86.38K | $-7.60 Million | 87.979x | +3053.32% |
| 2012-12-31 | $-1.07 Million | $-2.98 Million | 2.790x | -- |
About DarioHealth Corp
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to crea… Read more